(PubMed) Bertoia ML, Pai JK, Cooke JP, et al
Cirrhosis is somewhat extreme (compared with simple steatosis) since, besides the liver disease, which disrupts the liveralpha cell axis, individuals with cirrhosis are at high risk of kidney disease, which is often associated with hyperglucagonaemia [104]
16 This statement recommended that sponsors demonstrate the safety of their products for patients with cardiovascular (CV) disease, as most phase II and III trials excluded such patients
By providing a deeper understanding of the protective effects of GLP-1 RAs, this study underscores the potential for more targeted treatment strategies in managing diabetic AKD
We were interested in studying the effect of GLP-1 receptor agonists in uveitis, which is fundamentally an inflammatory eye disease, says Nitesh Mohan, a student at Cleveland Clinic Lerner College of Medicine who was lead author of the study